Today on TAP: The weekly roundup, and more fines for misconduct that won’t deter future misconduct
Big Pharma
Posted inHealth and Social Policy
How the Drug Industry Sacrifices Children With Cancer
The outrageous, contrived shortage of one of the most widely used generic cancer drugs, vincristine, reflects multiple policy failures.
Posted inHealth and Social Policy
This Pharma-Backed Astroturf Group Wants to Keep Your Drug Prices High
The Coalition Against Socialized Medicine, a project of the American Conservative Union, is advertising on Politico Playbook this week.
Posted inDay One Agenda
Force Drug Companies to Lower Prices
Presidents have two powerful sticks that could weaken the pharmaceutical industry’s power to rake in astronomical profits.
Posted inAmerica and the World
Trump Poised to Give Big Pharma a Big Present in India Trade Deal
Trump and Indian Prime Minister Narendra Modi are discussing an agreement that would lock the world’s second-most-populous country into exclusive prescription drug arrangements.
Posted inHealth and Social Policy
A Closer Look at Nancy Pelosi’s Plan for Lower Drug Prices
The bill, H.R. 3, has gotten considerably stronger from its initial concept, but questions remain.
Posted inHealth and Social Policy
The Insulin Racket
Insulin is a 100-year-old drug whose wholesale price has tripled in ten years. The reasons why explain everything wrong with America’s broken prescription drug market.
Posted inMoney, Politics, and Power
It’s Time To Go Further to End the Opioid Crisis
The rising death toll is a warning that Congress and the White House need to take more decisive action. If they can’t, or won’t, Americans should turn to the courts.
Posted inHealth and Social Policy
Before Big Pharma Kills Us, Maybe Public Pharma Can Save Us
Drug companies are abandoning antibiotic research to make more money elsewhere. Yet another reason why we need a publicly owned company.
Posted inEconomic Policy
We Need a Public Option for Prescription Drugs
Taxpayer dollars already fund the science behind new medications. Let’s create a public company to market them and bring their prices down.
